Home > Healthcare > Healthcare IT > Artificial Intelligence > Artificial Intelligence in Genomics Market

Artificial Intelligence in Genomics Market Share

Report ID: GMI6051
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Artificial Intelligence in Genomics Market Share

Major market players operating in the artificial intelligence in genomics market include

DEEP GENOMICS
Data4Cure, Inc.
Freenome Holdings, Inc.
Illumina, Inc.
SOPHiA GENETICS
Benevolent

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Artificial intelligence in genomics industry size reached USD 484.1 million in 2022 and is estimated to record USD 12.5 billion by 2032 attributed to the growing adoption of AI in precision medicine.

The software component segment accounted for 53.4% market share in 2022 and is poised to expand considerably through 2032 owing to the high demand for advanced analytics and ML capabilities in genomics research and clinical settings.

North America held 51.9% of the global AI in genomics market share in 2022 and is anticipated to grow at a robust CAGR through 2032 driven by the increasing investments for the advancement of AI-powered solutions for genomics by various research institutions.

Some of the major AI in genomics industry players include DEEP GENOMICS, Data4Cure, Inc., Freenome Holdings, Inc., Illumina, Inc., SOPHiA GENETICS, and Benevolent, and others.